These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32941852)

  • 1. Evaluation of a Competitive Equilibrium Dialysis Approach for Assessing the Impact of Protein Binding on Clearance Predictions.
    Jones RS; Chang JH; Flores M; Brecht E
    J Pharm Sci; 2021 Jan; 110(1):536-542. PubMed ID: 32941852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLM-beads: Rapid Assessment of Nonspecific Binding to Human Liver Microsomes Using Magnetizable Beads.
    Wang T; Whitcher-Johnstone A; Keith-Luzzi M; Chan TS
    Drug Metab Dispos; 2021 Dec; 49(12):1056-1062. PubMed ID: 34561223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Commonly Used and New Methods to Determine Small Molecule Non-Specific Binding to Human Liver Microsomes.
    Wang T; Whitcher-Johnstone A; Scaringella YS; Keith-Luzzi M; Shao J; Taub ME; Chan TS
    J Pharm Sci; 2024 Jul; 113(7):1987-1995. PubMed ID: 38615815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New method for the simultaneous estimation of intrinsic hepatic clearance and protein binding by matrix inhibition.
    Uchimura T; Kato M; Tachibana T; Arai S; Nabuchi Y; Saito K; Kinoshita H
    Biopharm Drug Dispos; 2008 Jan; 29(1):7-16. PubMed ID: 17941035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules.
    Trunzer M; Teigão J; Huth F; Poller B; Desrayaud S; Rodríguez-Pérez R; Faller B
    Drug Metab Dispos; 2024 Apr; 52(5):345-354. PubMed ID: 38360916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct determination of unbound intrinsic drug clearance in the microsomal stability assay.
    Giuliano C; Jairaj M; Zafiu CM; Laufer R
    Drug Metab Dispos; 2005 Sep; 33(9):1319-24. PubMed ID: 15951446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets.
    Winiwarter S; Chang G; Desai P; Menzel K; Faller B; Arimoto R; Keefer C; Broccatell F
    Mol Pharm; 2019 Sep; 16(9):4077-4085. PubMed ID: 31348668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of microsomal concentration on apparent intrinsic clearance: implications for scaling in vitro data.
    Kalvass JC; Tess DA; Giragossian C; Linhares MC; Maurer TS
    Drug Metab Dispos; 2001 Oct; 29(10):1332-6. PubMed ID: 11560877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the Time to Reach Equilibrium for Improved Estimation of the Unbound Fraction of Compounds in Equilibrium Dialysis Using kinetic Modeling.
    Bae C; Chung G; Chung SJ
    J Pharm Sci; 2023 Nov; 112(11):2901-2909. PubMed ID: 37392902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
    Kosugi Y; Hosea N
    Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based prediction of the nonspecific binding of drugs to hepatic microsomes.
    Li H; Sun J; Sui X; Yan Z; Sun Y; Liu X; Wang Y; He Z
    AAPS J; 2009 Jun; 11(2):364-70. PubMed ID: 19440845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of interpretability of two models of unbound fraction that are used in combination with the well-stirred model for predicting hepatic clearance of drugs.
    Poulin P
    J Pharm Sci; 2024 Nov; 113(11):3177-3190. PubMed ID: 39265660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.